NRXP icon

NRX Pharmaceuticals
NRXP

Overview Fund Trends Analyst Outlook Journalist POV

30 hedge funds and large institutions have $1.86M invested in NRX Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$58K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$296K
2
+$21K
3
+$19K
4
Renaissance Technologies
Renaissance Technologies
New York
+$16.8K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$7.58K

Top Sellers

1
-$84.5K
2
-$40.9K
3
-$17.5K
4
TSS
Two Sigma Securities
New York
-$13.8K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$9.28K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1K
27
$460
28
$100
29
$76
30
$34
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
1
2